Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Study of KK3910 in Healthy Volunteers and Patients With Essential HypertensionRecruiting
NCT06823947Phase 1Updated Jul 1, 2026
Sponsor: Kyowa Kirin Co., Ltd.
Healthy Volunteers Essential Hypertension
Japan
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruiting
NCT07291037Phase 3Updated Jul 1, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer (NSCLC)
United States, Australia, Austria, Belgium, Brazil +16 more
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseaseTerminated
NCT04173273Phase 2, Phase 3Updated Jul 1, 2026
Sponsor: Pfizer
Crohn's Disease
United States, Argentina, Australia, Austria, Belarus +36 more
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveActive Not Recruiting
NCT05831176Phase 2Updated Jul 1, 2026
Sponsor: Regeneron Pharmaceuticals
Eosinophilic Gastritis (EoG) · Eosinophilic Duodenitis (EoD) · Eosinophilic Gastrointestinal Disease (EGID) · Eosinophilic Gastroenteritis
United States, Canada, Italy, Japan
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Active Not Recruiting
NCT04162210Phase 3Updated Jul 1, 2026
Sponsor: GlaxoSmithKline
Multiple Myeloma
United States, Australia, Belgium, Brazil, Bulgaria +14 more
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Recruiting
NCT07431281Phase 3Updated Jul 1, 2026
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Adenocarcinoma · Esophageal Cancer
United States, Australia, Austria, Belgium, Brazil +17 more
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and ChemotherapyActive Not Recruiting
NCT04655976Phase 2, Phase 3Updated Jul 1, 2026
Sponsor: GlaxoSmithKline
Lung Cancer, Non-Small Cell
United States, Argentina, Australia, Belgium, Brazil +19 more
Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With SorafenibActive Not Recruiting
NCT02185560N/AUpdated Jul 1, 2026
Sponsor: Bayer
Thyroid Carcinoma
Japan
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without InhibitorsRecruiting
NCT05145127Phase 3Updated Jul 1, 2026
Sponsor: Pfizer
Hemophilia A · Hemophilia B
United States, Argentina, Australia, Brazil, Canada +19 more
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)Terminated
NCT06721156Phase 2Updated Jul 1, 2026
Sponsor: Merck Sharp & Dohme LLC
Alzheimer Disease · Dementia
United States, Argentina, Canada, Italy, Japan +4 more
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)Recruiting
NCT07611110Phase 3Updated Jul 1, 2026
Sponsor: AstraZeneca
Metastatic Castration-resistant Prostate Cancer
United States, Australia, Austria, Brazil, Canada +12 more
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical TrialsRecruiting
NCT04064060Phase 3Updated Jul 1, 2026
Sponsor: Celgene
Myelodysplastic Syndromes (MDS) · Beta-thalassemia · Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
United States, Australia, Belgium, Bulgaria, Canada +17 more
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)Active Not Recruiting
NCT05288166Phase 3Updated Jul 1, 2026
Sponsor: Eli Lilly and Company
Prostatic Neoplasms · Neoplasm Metastasis · Urogenital Neoplasms · Physiological Effects of Drugs
United States, Argentina, Australia, Belgium, Brazil +19 more
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal CancerRecruiting
NCT07079631Phase 1, Phase 2Updated Jul 1, 2026
Sponsor: BioNTech SE
Metastatic Colorectal Cancer
United States, Germany, Japan, Spain, United Kingdom
Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 DiabetesRecruiting
NCT06791291Phase 2Updated Jul 1, 2026
Sponsor: Sanofi
Type 1 Diabetes Mellitus
Japan
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)Active Not Recruiting
NCT02562235Phase 3Updated Jul 1, 2026
Sponsor: Bayer
Hypertension, Pulmonary
Colombia, Germany, Hungary, Italy, Japan +4 more
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT07184931Phase 3Updated Jul 1, 2026
Sponsor: Sanofi
Crohn's Disease
United States, Argentina, Australia, Austria, Belgium +26 more
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)Recruiting
NCT06057402Phase 4Updated Jul 1, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Australia, Canada, China, Japan +2 more
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)Recruiting
NCT06428409Phase 1, Phase 2Updated Jul 1, 2026
Sponsor: Merck Sharp & Dohme LLC
Colorectal Cancer · Pancreatic Ductal Adenocarcinoma · Biliary Tract Cancer
United States, Australia, Canada, Chile, China +8 more
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian CancerActive Not Recruiting
NCT02502266Phase 2, Phase 3Updated Jul 1, 2026
Sponsor: National Cancer Institute (NCI)
Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Endometrioid Adenocarcinoma · Fallopian Tube Serous Adenocarcinoma · Fallopian Tube Transitional Cell Carcinoma
United States, Canada, Japan, Puerto Rico, South Korea
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT07098338Phase 2Updated Jul 1, 2026
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Australia, Canada, China, France +7 more
A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic SeizuresRecruiting
NCT06657378N/AUpdated Jul 1, 2026
Sponsor: Eisai Co., Ltd.
Partial-Onset Seizures · Primary Generalized Tonic-clonic Seizures
Japan
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)Completed
NCT06873516Phase 2Updated Jul 1, 2026
Sponsor: Evommune, Inc.
Chronic Spontaneous Urticaria
United States, Canada, Japan
Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.Recruiting
NCT06812104Phase 1Updated Jul 1, 2026
Sponsor: Kyowa Kirin Co., Ltd.
Relapsed or Refractory AML and Other Hematologic Malignancies
Japan
Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)Recruiting
NCT04519619N/AUpdated Jun 30, 2026
Sponsor: Bayer
Neovascular Glaucoma
Japan

Previous page Next page